{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T10:46:22Z","timestamp":1763117182088,"version":"3.45.0"},"reference-count":10,"publisher":"Pan African Medical Journal","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pan Afr Med J"],"abstract":"<jats:p>Extranodal lymphoma involvement refers to lymphoma arising outside primary lymphatic organs. Muscular involvement is rare. This case report highlights the critical role of positron emission tomography-computed tomography (PET-CT) in detecting underestimated extranodal lesions, especially in muscles. We report the case of a 66-year-old patient with no prior significant medical history who presented with 3 months of cervical lymphadenopathy, asthenia, and night sweats. Examination revealed supracentimetric elastic cervical and inguinal lymphadenopathy and splenomegaly. Computed tomography suggested nodal disease above and below the diaphragm. Biopsy confirmed grade 3B follicular lymphoma and bone marrow infiltration. Positron emission tomography-computed tomography revealed intense fluorodeoxyglucose (FDG) uptake in nodal regions, spleen, bone marrow, and left masseter muscle, which was not visible on CT. The disease was staged as Ann Arbor stage IV, and the patient was planned for 8 cycles of R-CHOP and intrathecal methotrexate. As a final point, 18F-FDG PET\/CT is indispensable for accurate staging and assessment of treatment response in follicular lymphoma, permitting detection of extranodal disease not visible on CT.<\/jats:p>","DOI":"10.11604\/pamj.2025.52.96.49728","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T10:42:00Z","timestamp":1763116920000},"source":"Crossref","is-referenced-by-count":0,"title":["A hidden site: positron emission tomography-computed tomography (PET-CT) unveils subclinical masseter involvement in follicular lymphoma: case report"],"prefix":"10.11604","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3921-4455","authenticated-orcid":false,"given":"Sana","family":"Ferchichi","sequence":"first","affiliation":[{"name":"Department of Otorhinolaryngology, Ear and Head and Neck (ENT) Surgery, Taher Ma\u00e2mouri Hospital, Nabeul, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7244-5969","authenticated-orcid":false,"given":"Hamida Kh\u00e9miri","family":"Guerbouj","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Taher Maamouri Hospital, Nabeul, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Jouini","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Ear and Head and Neck (ENT) Surgery, Taher Ma\u00e2mouri Hospital, Nabeul, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghada","family":"Kharrat","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Ear and Head and Neck (ENT) Surgery, Taher Ma\u00e2mouri Hospital, Nabeul, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3277-5226","authenticated-orcid":false,"given":"Wafa","family":"Skouri","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Taher Maamouri Hospital, Nabeul, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haifa","family":"Tounsi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Taher Maamouri Hospital, Nabeul, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raja","family":"Amri","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Taher Maamouri Hospital, Nabeul, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4870","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"Jackson D, Ryan AG, Walsh E, Bolger M, Hennessy B, ElHassadi E et al. Musculoskeletal manifestations of lymphoma: a case series. BJR Case Rep. 2022 Sep 12;8(5):20210182. PubMed | Google Scholar","DOI":"10.1259\/bjrcr.20210182"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Binici DNR, Karaman A, Timur O, Tasar PNT, Sanibas AV. Primary skeletal muscle lymphoma: a case report. Mol Clin Oncol. 2018 Jan;8(1):80-82. PubMed | Google Scholar","DOI":"10.3892\/mco.2017.1483"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Kashyap R, Rai Mittal B, Manohar K, Balasubramanian Harisankar CN, Bhattacharya A, Singh B et al. Extranodal manifestations of lymphoma on [18] FDG-PET\/CT: a pictorial essay. Cancer Imaging. 2011 Nov 26;11(1):166-74. PubMed | Google Scholar","DOI":"10.1102\/1470-7330.2011.0023"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Karunanithi S, Soundararajan R, Sharma P, Naswa N, Bal C, Kumar R. Spectrum of physiologic and pathologic skeletal muscle 18F-FDG uptake on PET\/CT. AJR Am J Roentgenol. 2015 Aug;205(2):W141-9. PubMed | Google Scholar","DOI":"10.2214\/AJR.14.13457"},{"key":"ref4","unstructured":"Alamdari A, Naderi N, Peiman S, Shahi F. Non-Hodgkin lymphoma with primary involvement of skeletal muscle. Int J Hematol Oncol Stem Cell Res. 2014 Jul 1;8(3):55-7. PubMed | Google Scholar"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Burton E, Schafernak K, Morgan E, Samet J. Skeletal muscle involvement in B-cell lymphoma: two cases illustrating the contribution of imaging to a clinically unsuspected diagnosis. Case Rep Radiol. 2017:2017:2068957. PubMed | Google Scholar","DOI":"10.1155\/2017\/2068957"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Othman AIA, Nasr M, Abdel-Kawi M. Beyond lymph nodes: 18F-FDG PET\/CT in detection of unusual sites of extranodal lymphoma. Egypt J Radiol Nucl Med. 2019 Sep 17;50(1):29. Google Scholar","DOI":"10.1186\/s43055-019-0011-1"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Le Dortz L, De Guibert S, Bayat S, Devillers A, Houot R, Rolland Y et al. Diagnostic and prognostic impact of 18F-FDG PET\/CT in follicular lymphoma. Eur J Nucl Med Mol Imaging. 2010 Dec;37(12):2307-14. PubMed | Google Scholar","DOI":"10.1007\/s00259-010-1539-5"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Albano D. 18F-FDG PET\/CT impact in grade 3B follicular lymphoma. Br J Haematol. 2024 Dec;205(6):2134-2135. PubMed | Google Scholar","DOI":"10.1111\/bjh.19852"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Barraclough A, Lee ST, Villa D, Hapgood G, Wilson D, Chong G et al. The value of semiquantitative PET features and end-of-therapy PET in grade 3B follicular lymphoma. Br J Haematol. 2024 Dec;205(6):2254-2261. PubMed | Google Scholar","DOI":"10.1111\/bjh.19823"}],"container-title":["Pan African Medical Journal"],"original-title":[],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T10:42:10Z","timestamp":1763116930000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.panafrican-med-journal.com\/content\/article\/52\/96\/full\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":10,"URL":"https:\/\/doi.org\/10.11604\/pamj.2025.52.96.49728","relation":{},"ISSN":["1937-8688"],"issn-type":[{"value":"1937-8688","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"article-number":"49728"}}